Cambridge Equities, LP

CIK 1629222 · last filed 2024-02-20

Cambridge Equities, LP is a corporate insider who has filed 6 SEC Form 4 insider transactions across 4 companies since 2015. Across all open-market trades the lifetime net is +$25.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $268.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$268.79M

Companies

4

Total Filings

6

Lifetime Open-Market Net

$25.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
IBRX	10%+ Owner	37,857,346	$7.10	$268.79M	$0	1	2023-09-13
NantHealth, Inc. (NH) Delisted	10%+ Owner	4,147,608	$1.35	$5.60M	$25.00M	1	2021-04-15
ImmunityBio, Inc. (NK) Delisted	10%+ Owner	6,218,326	—	—	$0	2	2017-01-04
Sorrento Therapeutics, Inc. (SRNE) Delisted		0	$0.00	$0	$0	1	2016-07-11

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-02-20	—	Buy (P)	+1,769,192	$2.69M
2023-09-13	IBRX	Mixed	+1,046,459,680	$1.35B	EDGAR
2021-04-15	NantHealth, Inc. (NH) Delisted	Mixed	+8,445,945	$25.00M	EDGAR
2017-01-04	ImmunityBio, Inc. (NK) Delisted	Gift (G)	−1,350,000	$0	EDGAR
2016-07-11	Sorrento Therapeutics, Inc. (SRNE) Delisted	Mixed	−31,512,392	$0	EDGAR
2015-10-16	ImmunityBio, Inc. (NK) Delisted	Buy (P)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.